$Rani Therapeutics (RANI.US)$ NEWS Rani Therapeutics to Pres...
NEWS
Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024
Rani Therapeutics, a clinical-stage biotherapeutics company, will present clinical and preclinical data on their oral delivery platform, the RaniPill® capsule, at Digestive Disease Week 2024. The data will focus on the oral delivery of an Ustekinumab biosimilar, showcasing high bioavailability in healthy human participants and canines. The presentations will take place virtually and in-person on May 18-21, 2024, in Washington, DC. Positive Rani Therapeutics showcasing high bioavailability of Ustekinumab biosimilar delivered via the RaniPill® capsule in human participants and canines. Selection of abstracts by the American Gastroenterological Association (AGA) for presentation at Digestive Disease Week 2024.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
702Followers
75Following
4403Visitors
Follow